Literature DB >> 12100860

In vitro experiment optimization for measuring tetrahydrocannabinol skin permeation.

Prasad V N Challapalli1, Audra L Stinchcomb.   

Abstract

The purpose of this study was to optimize in vitro experimental conditions for the measurement of Delta(9)-tetrahydrocannabinol (Delta(9)-THC) permeation across human skin using a flow-through diffusion cell system. The drug permeation rates through intact and stripped (stratum corneum (SC) removed) skin were also compared in order to determine if the SC provided significant resistance to the diffusion of hydrophobic Delta(9)-THC. The receiver fluids evaluated were HEPES-buffered Hank's balanced salt solution (HHBSS) with either 4 or 6% bovine serum albumin (BSA), Polyoxyethylene 20 Oleyl Ether (Brij 98) solution (0.5 and 6.0%), and hydroxypropyl-beta-cyclodextrin (HPBCD). The Delta(9)-THC permeability was significantly higher into Brij 98 solutions than into 4% BSA. BSA 6% receiver solutions showed significantly higher Delta(9)-THC permeation over BSA 4%. There were no significant differences in Delta(9)-THC permeability or lag time values between 0.5 and 6% Brij 98 receiver solutions. HPBCD failed to work as a suitable receiver solution. The Delta(9)-THC flux in the stripped skin experiments exceeded the flux in the intact skin experiments. It appears that the SC provides some resistance to the diffusion of Delta(9)-THC across human skin. These experimental results have confirmed the utility of several receiver solutions for the in vitro human skin diffusion study of Delta(9)-THC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100860     DOI: 10.1016/s0378-5173(02)00262-4

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  13 in total

Review 1.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

2.  Influence of plasticizers on the stability and release of a prodrug of Delta(9)-tetrahydrocannabinol incorporated in poly (ethylene oxide) matrices.

Authors:  Sridhar Thumma; Mahmoud A ElSohly; Shuang-Qing Zhang; Waseem Gul; Michael A Repka
Journal:  Eur J Pharm Biopharm       Date:  2008-06-18       Impact factor: 5.571

Review 3.  The pharmacokinetics and the pharmacodynamics of cannabinoids.

Authors:  Catherine J Lucas; Peter Galettis; Jennifer Schneider
Journal:  Br J Clin Pharmacol       Date:  2018-08-07       Impact factor: 4.335

4.  Iontophoretically enhanced ciclopirox delivery into and across human nail plate.

Authors:  Jinsong Hao; Kelly A Smith; S Kevin Li
Journal:  J Pharm Sci       Date:  2009-10       Impact factor: 3.534

5.  Chemical stability and bioadhesive properties of an ester prodrug of Delta 9-tetrahydrocannabinol in poly(ethylene oxide) matrices: effect of formulation additives.

Authors:  Sridhar Thumma; Soumyajit Majumdar; Mahmoud A ElSohly; Waseem Gul; Michael A Repka
Journal:  Int J Pharm       Date:  2008-07-05       Impact factor: 5.875

6.  Transdermal delivery of the synthetic cannabinoid WIN 55,212-2: in vitro/in vivo correlation.

Authors:  Satyanarayana Valiveti; Dana C Hammell; D Caroline Earles; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

7.  Effects of JWH015 in cytokine secretion in primary human keratinocytes and fibroblasts and its suitability for topical/transdermal delivery.

Authors:  Alicia Bort; Perla A Alvarado-Vazquez; Carolina Moracho-Vilrriales; Kristopher G Virga; Giuseppe Gumina; Alfonso Romero-Sandoval; Scott Asbill
Journal:  Mol Pain       Date:  2017-01       Impact factor: 3.395

Review 8.  Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination.

Authors:  Joana Gonçalves; Tiago Rosado; Sofia Soares; Ana Y Simão; Débora Caramelo; Ângelo Luís; Nicolás Fernández; Mário Barroso; Eugenia Gallardo; Ana Paula Duarte
Journal:  Medicines (Basel)       Date:  2019-02-23

Review 9.  Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.

Authors:  Brigitta Kis; Feng Chen Ifrim; Valentina Buda; Stefana Avram; Ioana Zinuca Pavel; Diana Antal; Virgil Paunescu; Cristina Adriana Dehelean; Florina Ardelean; Zorita Diaconeasa; Codruta Soica; Corina Danciu
Journal:  Int J Mol Sci       Date:  2019-11-25       Impact factor: 5.923

10.  Cannabinoids in the management of difficult to treat pain.

Authors:  Ethan B Russo
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.